Clinical trials are an important step in our being able to have new treatments for diabetes and other conditions in order to carefully test a new drug or device in patients before it is approved by the FDA to be used in the general public. The American Diabetes Association is currently a partner providing support for the following clinical studies and initiatives:
• TrialNet Type 1 Diabetes TrialNet is an international network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes.
• GRADE GRADE is a comparative effectiveness study looking at what medications work best at lowering blood glucose levels in patients who are newly diagnosed with diabetes.
• RISE The Restoring Insulin Secretion study (RISE) includes 3 studies examining whether aggressive glucose lowering will lead to recovery of pancreas function in those with prediabetes and early type 2 diabetes.
• D2d The goal of the Vitamin D and type 2 diabetes (D2d) study is to determine whether vitamin D supplementation is safe and effective in delaying the onset of type 2 diabetes in people at risk for the disease, and to gain a better understanding of how vitamin D affects glucose metabolism.
Related Journals of Diabetes Clinical Trials
Journal of Clinical Diabetes & Practice, Journal of Diabetes & Metabolism, Diabetes Case Reports, Endocrinology & Diabetes Research, Journal of Childhood Obesity, Clinical Medicine Insights: Endocrinology and Diabetes, Experimental and Clinical Endocrinology & Diabetes, Current Opinion in Endocrinology and Diabetes, Journal of Diabetes Mellitus, Journal of Diabetes and its Complications, International Journal of Diabetes and Metabolism, International Journal of Diabetes